Sign in

NCT06783088Completed

Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D

Source: ClinicalTrials.gov · Last updated 23 Dec 2025

Brief summary (registry, in English)

The main of this study is to demonstrate the feasibility of carrying out quantitative acquisitions regardless of the energy peak considered (113 keV (kiloelectronVolts) or 208 keV or a combination of the 2 energy peaks). A study on phantom will optimise the reconstruction parameters. These parameters will then be applied to a population of patients who have already benefited from a recording on a 3D CZT camera (retrospective data).

Status (registry)
Completed
Study type
Observational
Enrollment
20 (actual)
First submitted
14 Jan 2025
Start date
10 Mar 2025
Primary completion date
10 Apr 2025
Lead sponsor
Central Hospital, Nancy, France
NCT number
NCT06783088

What you commit to

  • Study type: Observational
  • Participants enrolled: 20
  • From 10 Mar 2025 to the primary completion date, 10 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient having sent an objection to the use of their data

Who the study is looking for

  • Patients treated by at least one cure of lutetium vipivotide tetraxetan with imaging

Criteria the registry did not label

  • It is a retrospective study and the criteria to collect the imaging are:

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
CHRU Nancy
Coordinator of this site? Confirm its status
Vandœuvre-lès-NancyFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.